Summary.-Adenosine deaminase (EC 3.5.4.4, ADA) has been assayed in lymphocytes, granulocytes and erythrocytes from 45 patients with haematological malignancies. Activities were uniformly low in lymphocytes from patients with chronic lymphocytic leukaemia. Variable, but abnormal activities were frequently found in multiple myeloma, untreated lymphoma and leukaemic reticuloendotheliosis. High values were observed in lymphocytes from patients with lymphoma during intensive combination chemotherapy. ADA levels in lymphocytes were not correlated with levels in granulocytes or erythrocytes. ADA was elevated in blasts of patients with acute lymphocytic and myelogenous leukaemias but the ranges of activities per cell were so similar that ADA assay is unlikely to be of major help in distinguishing the two diseases.
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WE HAVE assayed adenosine deaminase (EC 3.5.4.4, ADA) in lymphocytes, granulocytes and erythrocytes from patients with a wide variety of haematological malignancies. The original working hypothesis was that ADA might be low in adults with haematological neoplasms and acquired immunodeficiency, since decreased to absent activity of ADA in erythrocytes and lymphocytes is associated with an inherited, autosomal recessive form of immunodeficiency disease of childhood (Giblett et al., 1972; Parkman et al., 1975) . Decreased levels of ADA have been reported in lymphoid cells from the peripheral blood of children with acute (Zimmer, Khalifa and Lightbody, 1975) and adults with chronic (Scholar and Calabresi, 1973; Tung et al., 1974) lymphocytic leukaemia, most of whom would be immunodeficient to some degree.
High values of ADA occur in the blast cells of patients with acute lymphocytic, acute myeloid, chronic mveloid and chronic myeloid blastic crisis leukaemia, (Smyth and Harrap, 1975) . Because ADA was usually higher in lymphoblasts than myeloblasts, Smyth and Harrap postulated that measurement of ADA might be useful diagnostically in the undifferentiated acute leukaemias. We also find very high ADA activities in blasts in the acute leukaemias but the range of values observed is so broad that no clear distinction between myelogenous and lymphocytic leukaemia can be made. Patients with chronic lymphocytic leukaemia uniformly have low ADA in lymphocytes so that measurement of ADA might be of diagnostic help in evaluating a mild lymphocytosis of unknown cause.
MATERIALS AND METHODS
Informed consent wAas obtained from blood donors. The project was approved by the Committee on Human Investigation of the University of Kentucky and the Lexington Veterans Administration Hospital. Methods for assay of ADA in cells of peripheral blood have been described in more detail in an earlier publication (Coleman and Hutton, 1975a) .
Cell separation and preparation of extracts.-Fractionation of lymphocytes, granulocytes and erythrocytes was routinely carried out on 10-20 ml of freshly drawn, heparinized blood. Erythrocytes were separated from leucocytes by dextran sedimentation and the leucocyte fraction was then layered on to a Ficoll-Hypaque gradient (Boyum, 1968) Assay of adenosine deaminase.-Adenosine deaminase levels in the cell extracts were measured by following the conversion of 14C-adenosine to 14C-inosine (Coleman and Hutton, 1975a) . The reaction mixture contained 50 mmol/l potassium phosphate buffer, pH 7-0, and 0-25 mmol/l 14C-adenosine (Schwarz/Mann, sp. act. 3150 ct/min/nmol). The apparent Km of the ADA for adenosine was estimated to be 5 X 10-5 mol so that maximal velocity is achieved in our system. Assay was performed by mixing 25 ,ud of tissue extract with 100 ,ul of the reaction mixture, incubating at 37°C and withdrawing 20 ,A aliquots at 5, 10, 15 and 20 min. The aliquots were spotted on to strips of Whatman DE-81 chromatography paper along with 5 ,ul of non-radioactive inosine (2 mg/ml). The strips were chromatographed for 1 h in 1 mmol/l ammonium formate by descending chromatography. They were then dried in an oven at 80°C. The inosine spots were located with an ultraviolet lamp, cut out and counted in toluene-0 4% BBOT (2.5-bis-2-(5-tert-butylbenzoxazolyl)-thiophene) cocktail using a scintillation counter. One unit of enzyme activity is equal to 1 nmol 14C-inosine produced per min. Specific activity is expressed as units of activity per 108 cells.
Sucrose gradients.-5-20% (w/v) sucrose gradients were prepared in 25 mmol/l Tris Cl, pH 8-0, 500 mmol/I NaCl, 1 mmol/l mercaptoethanol and 1 mmol/l EDTA. 0'2 ml samples of the cell extracts were dialysed several hours against the same buffer without the sucrose and layered on top of the gradients. The gradients were centrifuged at 40,000 rev/min for 16 h at 4°C in a Spinco SW 50.1 rotor. Twenty fractions (0.25 ml)
were collected from each gradient by displacement with 50% sucrose. Each fraction was assayed for adenosine deaminase activity by adding 10 ,ul of the gradient fraction to 50 ,ul of adenosine deaminase reaction mix.
RESULTS
A survey of adenosine deaminase activities in erythrocytes, granulocytes and lymphocytes from normal people and patients with haematological diseases is presented in Table I . The normal group consisted of 22 adults, ranging in age from 23 to 60 years, who had no evidence of malignant disease. The level of activity in normal lymphocytes ranged from 103 to 205 U/108 cells with a mean of 144 and a standard error of 5. ADA levels in lymphocytes of 5 patients with untreated chronic lymphocytic leukaemia (CLL) ranged from 31 to 80 u/108 cells, which is significantly below the normal range (Tables I and II , P < 0-01 by Student's " t " test). Most of these patients had minimal disease without evidence of gross organomegaly, haemolytic anaemia or other complications. Patients with longstanding or aggressive CLL had similar low activities of ADA in their lymphocytes. These patients were being treated with alkylating agents, steroids and other agents. Antileukaemic therapy and control of gross disease did not result in increased levels of ADA in lymphocytes (Table II) . There were no t Patients were receiving one or more cancer chemotherapeutic agents at the time blood was obtained.
Specific information about the drugs used in one group of patients, CLL, presented in Table II . Because of the complexity of the chemotherapy and the lack of correlation between ADA and specific agents, further details about treatment are omitted. t Patients in remission had received extensive chemotherapy or radiation therapy, but this had been discontinued at least one year before study. At the time blood was obtained there was no clinical evidence of recurrence of lymphoma. (Coleman and Hutton, 1975a Tung et al. (1974) who found that ADA levels increased toward normal in treated cases of CLL. ADA activities remained normal in granulocytes and erythrocytes of patients with treated and untreated CLL (Table I) . Two patients with untreated leukaemic reticuloendotheliosis were studied. In one case the ADA activity in lymphocytes was very low (54 U/108 cells) whereas in the second patient the value was higher (110 u/108 cells) and closer to normal (Table I) .
Blasts from patients with acute lymphocytic (ALL) and acute myelogenous (AML) leukaemia had levels of ADA activity 2 to 10-fold higher than lymphocytes of normal individuals (Table I Regardless of changes in ADA activity in lymphocytes, no consistent abnormalities were observed in erythrocytes or granulocytes (Table I) . ADA values in extracts of granulocytes were remarkably constant in all the groups studied. There was greater variability in the red cell ADA values but in no group was there an extreme deviation from the control values. Because ADA activity is so low in erythrocytes compared with nucleated cells, minor degrees of contamination of erythrocytes with nucleated cells would elevate the apparent red cell ADA activity. Such contamination was monitored both by morphological examination of cell preparations and by differential particle counts before and after detergent treatment of cell suspensions. Contamination of erythrocytes with nucleated cells was generally less than 0.2% and ADA values in erythrocytes were corrected to eliminate the contribution of granulocytes and lymphocytes.
Since ADA activities were much higher in lymphoblasts of children with ALL than in normal lymphocytes, the effect of chemotherapy on ADA values was monitored in 5 children. Initial peripheral leucocyte counts ranged from 40,000 to 400,000/ldl with 80-95% lymphoblasts. The specific activities of ADA in the blasts ranged from 349 to 2650 u/108 cells. The capacity of blasts from these patients to form E rosettes with sheep red blood cells has been reported (Coleman et al., 1976 Deviation from normal levels of ADA activity was consistently observed in lymphocytes of chronic lymphocytic leukaemia and in blast cells of acute myelogenous and acute lymphocytic leukaemias. This observation prompted an investigation of possible alterations in the molecular weight of the enzyme in association with these diseases since there are two species of ADA which differ in molecular weight (Akedo et al., 1972; Osborne and Spencer, 1973) . Cell extracts were sedimented through 5-20% sucrose gradients, as seen in Fig. 2 (Fig. 2) .
DISCUSSION
The recent development of a convenient, sensitive radiometric method of assaying ADA in small numbers of cells from peripheral blood (Coleman and Hutton, 1975a) Scholar and Calabresi (1973) and Tung et al. (1974) have reported similar results in lymphocytes. The latter investigators found that ADA activity increased following chemotherapy, which is not supported by the data presented in Table II (Coleman and Hutton, 1975b) .
ADA activity was elevated in blasts from patients with acute lymphocytic and acute myelogenous leukaemia. Differences in the specific activity per cell were insufficient and too variable to permit use of ADA as a biochemical marker for distinguishing the two types of blasts (Table I) . We monitored ADA activity in the blood of 5 children during chemotherapy for acute lymphocytic leukaemia in order to see whether it could serve as a biochemical marker for the presence of abnormal cells in the peripheral blood. ADA values in peripheral lymphoid cells returned to normal as remission was achieved. There was no suggestion that ADA would be a useful biochemical marker of disease activity and completeness of remission.
The cause of alterations of ADA activity in lymphoproliferative diseases is not clear. Certainly variation in the stage of immunological maturation of the circulating lymphocyte may be important because leukaemic lymphoblasts, human thymocytes and lymphoblastoid cell lines all have high levels of ADA, when compared with normal mature circulating lymphocytes (Coleman and Hutton, 1975b) . Elevated levels of ADA in lymphocytes would indicate changes in the degree of immunological activity compared to normal. Low values seem generally to be associated with abnormal B cell proliferation.
Our conclusion after assaying ADA in lymphocytes, granulocytes and erythrocytes of 45 patients with haematological disease is that the procedure is too laborious for the limited amount of information derived. Assay of the enzyme is rapid and inexpensive, lending itself to population surveys. It is the cell separation procedure that is time-consuming and expensive, prohibiting routine survey of populations. Cell separation techniques are necessary, however, because of the lack of correlation among erythrocyte, granulocyte and lymphocyte ADA levels except in case of profound hereditary deficiency due presumably to a structural mutation in the common catalytic unit. Even the lowest values of ADA observed in adult lymphocytes did not seem far enough below normal to cause disordered purine catabolism which could affect lymphocyte function and explain acquired immunodeficiency. This should be tested, however, by measuring the purine content of lymphocytes in chronic lymphocytic leukaemia. 
